First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Genex
Blog
Transportation and translation: an unlikely but powerful duo
Recently, the Sounding Board sat down with Jim Begg, Vice President of National Accounts for Apricus, to talk about transportation and translation
Genex
CE Webinar
Knee Injuries: Trends and Advances [Recording]
On-Demand
Knee injuries make up a large percentage of medical insurance and health care claims in the orthopedic field.
Mitchell
News Release
FDA Approves Higher Dose Naloxone, Kloxxado
Naloxone has been known by different brand names over the years as the primary treatment of opioid overdose.
Genex
News Release
Mitchell | Genex | Coventry Signs Agreement to Acquire QualCare Alliance Networks Inc.
Deal will strengthen company's network in New Jersey
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge